ProUroCare seeks FDA approval for prostate cancer monitoring device

11/29/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

ProUroCare Medical has submitted an application to the FDA seeking approval for a device that can generate 3-D images of the prostate gland to track prostate cancer. The startup firm said its technology quantifies tissue elasticity to enable physicians to conduct preliminary biopsies and monitor cancer progression.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC